-transparent.png){kind=logo}
6-Nitroquipazine has been known as one of the most potent and selective inhibitors of serotonin transporter in vitro and in vivo. Nine derivatives of 6-nitroquipazine were synthesized and tested for their potential abilities to displace [3H]citalopram binding to the rat cortical membranes.
Related Publications
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
May 2007,
Bioorganic & medicinal chemistry,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
August 2005,
Bioorganic & medicinal chemistry,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
December 1999,
Bioorganic & medicinal chemistry letters,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
December 2000,
Bioorganic & medicinal chemistry letters,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
March 2012,
European journal of medicinal chemistry,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
April 1979,
Journal of medicinal chemistry,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
September 1994,
The Journal of pharmacy and pharmacology,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
November 1993,
International journal of peptide and protein research,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
July 1996,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B S Lee, and
S Chu, and
B C Lee, and
D Y Chi, and
Y S Choe, and
K J Jeong, and
C Jin
July 1999,
Nuclear medicine and biology,
